| abstract |
Disclosed are stable compositions comprising at least one CB2 receptor selective or highly selective agonist and optionally at least one antipsychotic for use in the treatment of mental disorders, methods of preparing such compositions and methods of treating mental disorders using same. Disclosed are also compositions comprising beta caryophyllene (BCP) or HU-308 for use in the treatment of mental disorders one of which is schizophrenia, methods of making such compositions and methods of treating mental disorders one of which is schizophrenia. |